Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHB2400070	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2024-04-11					view
JXHB2400071	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2024-04-11					view
JXHL2300224	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2023-09-15					view
JXHB2300105	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2023-06-19					view
JXHL2101209	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2021-10-19					view
JXHB2101053	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2021-08-09					view
JXHB2100017	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2021-01-28	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2021-01-27	view
JXHB2100016	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2021-01-28	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2021-01-27	view
JXHB2100018	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2021-01-28	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2021-01-27	view
JXHL2000229	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2020-08-21	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2020-08-19	view
JXHL2000233	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2020-08-21	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2020-08-19	view
JXHL2000230	SAR442168	tolebrutinib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2020-08-21	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2020-08-19	view